Table 2. Feasibility of paclitaxel, ifosfamide, and cisplatin (n=152).
| Parameter | No. (%) |
|---|---|
| Cycles of treatment, median (range) | 3 (1-3) |
| Treatment delay | 10 (7) |
| Toxicity | 10 (7) |
| Treatment withdrawal | 13 (9) |
| Toxicity | 12 (8) |
| Refusal | 1 (1) |
| Treatment limiting toxicities* | 23 |
| Neutropenia | 11 (48) |
| Anemia | 10 (43) |
| Thrombocytopenia | 7 (30) |
| Renal failure | 3 (13) |
| Allergic reaction | 3 (13) |
| Vomiting | 3 (13) |
| Febrile neutropenia | 2 (9) |
| Hypopotassemia | 2 (9) |
| Atrial fibrillation | 1 (4) |
*Toxicities requiring treatment delay or withdrawal.